Ebina, Teresita P.
HRN: 21-84-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/01/2023
09/08/2023
IV
500mg
Q8
Intra-abdominal Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes